Get started
Sana Biotechnology, Inc.Sana Biotechnology, Inc.Sana Biotechnology, Inc.

Sana Biotechnology, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

SANA chart


Full chart

SANA upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪779.21 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.41 USD
Net income (FY)
‪−283.25 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪122.70 M‬
Beta (1Y)
−0.46

Employees


Employees (FY)
328
Change (1Y)
−93 −22.09%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−863.58 K‬ USD

About Sana Biotechnology, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Steven D. Harr
Website
sana.com
Headquarters
Seattle
Founded
2018
FIGI
BBG00N5BMH61
Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

SANA news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of SANA is 3.38 USD — it has increased by 0.29% in the past 24 hours. Watch Sana Biotechnology, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Sana Biotechnology, Inc. stocks are traded under the ticker SANA.
SANA stock has risen by 11.11% compared to the previous week, the month change is a 114.72% rise, over the last year Sana Biotechnology, Inc. has showed a −37.17% decrease.
We've gathered analysts' opinions on Sana Biotechnology, Inc. future price: according to them, SANA price has a max estimate of 16.00 USD and a min estimate of 7.00 USD. Watch SANA chart and read a more detailed Sana Biotechnology, Inc. stock forecast: see what analysts think of Sana Biotechnology, Inc. and suggest that you do with its stocks.
SANA reached its all-time high on Feb 10, 2021 with the price of 44.60 USD, and its all-time low was 1.52 USD and was reached on Dec 30, 2024. View more price dynamics on SANA chart.
See other stocks reaching their highest and lowest prices.
SANA stock is 9.61% volatile and has beta coefficient of −0.46. Track Sana Biotechnology, Inc. stock price on the chart and check out the list of the most volatile stocks — is Sana Biotechnology, Inc. there?
Today Sana Biotechnology, Inc. has the market capitalization of ‪779.21 M‬, it has increased by 109.70% over the last week.
Yes, you can track Sana Biotechnology, Inc. financials in yearly and quarterly reports right on TradingView.
Sana Biotechnology, Inc. is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
SANA earnings for the last quarter are −0.25 USD per share, whereas the estimation was −0.26 USD resulting in a 2.78% surprise. The estimated earnings for the next quarter are −0.25 USD per share. See more details about Sana Biotechnology, Inc. earnings.
Sana Biotechnology, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
SANA net income for the last quarter is ‪−59.92 M‬ USD, while the quarter before that showed ‪−50.29 M‬ USD of net income which accounts for −19.15% change. Track more Sana Biotechnology, Inc. financial stats to get the full picture.
No, SANA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 24, 2025, the company has 328.00 employees. See our rating of the largest employees — is Sana Biotechnology, Inc. on this list?
Like other stocks, SANA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sana Biotechnology, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sana Biotechnology, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sana Biotechnology, Inc. stock shows the sell signal. See more of Sana Biotechnology, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.